UCI MEDICAL AFFILIATES INC
NT 10-K, 1998-12-30
SPECIALTY OUTPATIENT FACILITIES, NEC
Previous: CELLCOM CORP, NT 10-K, 1998-12-30
Next: CORRECTIONS CORPORATION OF AMERICA, 424B2, 1998-12-30



- ------------------------------------------------------------------------
                     FORM 12b-25 NOTIFICATION OF LATE FILING
- ------------------------------------------------------------------------

                               SEC FILE NUMBER
                                0-13265
                               CUSIP NUMBER
                               902633 10 6
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 (Check One):    X  Form 10-K  Form 20-F  Form 11-K   
                                          Form 10-Q  Form N-SAR
For Period Ended: __September 30, 1998
[ ]  Transition  Report  on Form  10-K 
[ ]  Transition  Report  on Form 20-F 
[ ]  Transition Report on Form 11-K 
[ ]  Transition Report on Form 10-Q 
[ ]  Transition Report on Form N-SAR
For the Transition Period Ended: __________________________
Read Instruction (on back page) Before Preparing Form. Please Print or Type.
Nothing in this form shall be construed to imply that the Commissions has
verified any information contained herein.
- ---------------------------------------------------------------------------
If the notification  relates to a portion of the filing checked above,  identify
the item(s) to which the notification relates:
- --------------------------------------------------------------------
- --------------------------------------------------------------------

PART 1--REGISTRANT INFORMATION (Official Text)
UCI Medical Affiliates, Inc.
Full Name of Registrant:
- -----------------------
Former Name if Applicable

1901 Main Street, Suite 1200, Mail Code 1105
Address of Principal Executive Office (Street and Number)

Columbia, South Carolina  29201
City, State and Zip Code


<PAGE>


PART II--Rules 12b-25(b) AND (c) (Official Text)
If the subject report could not be filed without  unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate
     ( X ) (a) The reasons  described in  reasonable  detail in Part III of this
form could not be eliminated without unreasonable effort or expense;
     ( X ) (b) The subject annual report,  semi-annual report, transition report
on Form 10-K, Form 20-F, 11-K, Form N-SAR, or portion thereof,  will be filed on
or before the fifteenth  calendar day following the  prescribed due date; or the
subject  quarterly report of transition  report on Form 10-Q, or portion thereof
will be filed on or before the fifth  calendar day following the  prescribed due
date; and
     ( X ) (c) The  accountant's  statement  or other  exhibit  required by Rule
12b-25(c) has been attached if applicable.

PART III--NARRATIVE (Official Text)
     State below in reasonable detail the reasons why the Form 10-K, 11-K, 10-Q,
N-SAR, or the transition  report or portion  thereof,  could not be filed within
the prescribed time period. (Attach Extra Sheets if Needed)

         The filing of Form 10-KSB by UCI Medical  Affiliates,  Inc., is delayed
         as the  result of  unforeseen  difficulties  in the  completion  of the
         Company's  annual  audit  by  PricewaterhouseCoopers,  LLP for the year
         ended September 30, 1998.

         The Company has recorded several  significant  transactions  during the
         fourth quarter including the possible sale of a significant  portion of
         the Company which  required the Company to delay the start of the audit
         and a divesture  of a small  division of the Company in late  September
         1998 which has added to the  auditors  workload and  necessitates  this
         extension.  A  statement  concerning  this  delay  from  the  Company's
         auditors is included in this filing as an exhibit.

         The delay in this filing of Form 10-KSB could not be eliminated without
unreasonable effort or expense.



<PAGE>


PART IV--OTHER INFORMATION (Official Text)
 (1) Name and telephone number of person to contact in regard to this 
     notification

Jerry F. Wells, Jr., CPA, EVP of Finance and CFO  (803)                252-3661
- ------------------------------------------------ ------------------------------
  (Name)                                        (Area Code)   (Telephone Number)

(2) Have all other  periodic  reports  required under Section 13 or 15(d) of the
Securities  Exchange Act of 1934 or Section 30 of the Investment  Company Act of
1940  during  the  preceding  12  months  or for such  shorter  period  that the
registrant  was  required to file such  report(s)  been filed?  If answer is no,
identify report(s). ( X ) Yes ( )No

(3) Is it anticipated that any significant  change in results of operations from
the  corresponding  period for the last  fiscal  year will be  reflected  by the
earnings  statement to be included in the subject report or portion thereof? 
( X ) Yes ( ) No

If so, explain the anticipated change, both narratively and quantitatively, and,
if  appropriate,  state the  reasons  why a  reasonable  estimate of the results
cannot be made.

         During the fourth quarter of the fiscal year ended  September 30, 1998,
         the  Company  made the  decision to divest of its  unprofitable  Family
         Practice   Division.   The   resulting   loss  from  this  disposal  of
         approximately  $856,000 and the  write-off  goodwill from this division
         and of goodwill  for other  underperforming  practice  acquisitions  of
         approximately  $1,864,000 have been recorded as a reduction of earnings
         for the Company in the fourth quarter of fiscal year 1998.

         Additionally,  a deferred tax benefit of  approximately  $1,753,000 has
         been  fully  reserved  against  since  the  Company  has not  posted an
         operating  profit in fiscal  year 1998 and cannot be certain of taxable
         earnings  significant enough in the future to ensure the utilization of
         expiring net operating loss carryforwards.

         The above fourth quarter events will result in a significant  change in
the results of the Company from its previous year.

         UCI Medical Affiliates, Inc.
(Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned 
hereunto duly authorized.

Date:    December 28, 1998         By:  /s/ Jerry F. Wells, Jr., CPA
         ------------------
                                        Jerry F. Wells, Jr., CPA
                                        Executive Vice President of Finance
                                        and Chief Financial Officer

INSTRUCTION: The form may be signed by an executive officer of the registrant or
by any other duly  authorized  representative.  The name and title of the person
signing  the form  shall  be typed or  printed  beneath  the  signature.  If the
statement is signed on behalf of the registrant by an authorized  representative
(other than an executive officer), evidence of the representative's authority to
sign on  behalf  of the  registrant  shall be filed  with  the  form.  

ATTENTION
Intentional  misstatements  or omissions  of fact  constitute  Federal  Criminal
Violations (See 18 U.S.C. 1001).


<PAGE>


                             EXHIBIT TO FORM 12b-25




Mr. Jerry Wells, CFO
UCI Medical Affiliates, Inc.
Suite 1200
1900 Main Street
Columbia, SC  29201



December 28, 1998

Dear Mr. Wells:

You have furnished us with a copy of your  "Notification of Late Filing" on Form
12b-25 dated December 28, 1998.

We are in agreement with the comments under Part III of the Form with respect to
the reasons why we are unable to furnish our report on the financial  statements
of UCI  Medical  Affiliates,  Inc.  on or before the date the Form 10-KSB of UCI
Medical Affiliates, Inc. for the year ended September 30, 1998 is required to be
filed.

Yours very truly,



/s/ PricewaterhouseCoopers LLP

PricewaterhouseCoopers LLP




THE ORIGINAL SIGNED LETTER ON PRICEWATERHOUSECOOPER LLP LETTERHEAD IS ON FILE IN
THE CORPORATE OFFICES OF UCI MEDICAL AFFILIATES, INC.







© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission